Myriad Genetics survey: Women have widespread confusion and misconceptions about ovarian cancer screening

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, today revealed new nationwide survey results indicating widespread confusion and misconceptions about ovarian cancer screening among a majority of women.

Trump, and tech tycoons, stoke health AI hype with Stargate

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in

January 23, 2025

Smoking linked to increased risk of depression, bipolar disorder

Most of us know that smoking is unhealthy. Cigarette packets display shocking picture warnings of diseased lungs and rotting teeth. And we often hear in

August 30, 2023

3 addiction and drug policy issues to watch in 2025

The new year and new presidential administration could mark a significant shift in the U.S. response to the opioid crisis. While drug deaths trended steadily

December 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.